>
4DMedical logo

4DX - 4DMedical Share Price

A$1.38 0.1  6.2%

Last Trade - 18/06/21

Sector
Healthcare
Size
Small Cap
Market Cap £197.5m
Enterprise Value £174.5m
Revenue £154k
Position in Universe 486th / 1914
Bullish
Bearish
Unlock 4DX Revenue
Momentum
Relative Strength (%)
1m -0.21%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -53.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.68 1.38 0.70 1.23 2.33 3.74 +21.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, 4DMedicalLtd revenues decreased 86% to A$151K. Net loss increasedfrom A$5.4M to A$13.1M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Higher net loss reflectsInterest expense on borrowings increase from A$747K toA$2.6M (expense), Legal, professional and consultant expenincrease from A$1.1M to A$2.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4DX Revenue Unlock 4DX Revenue

Net Income

4DX Net Income Unlock 4DX Revenue

Normalised EPS

4DX Normalised EPS Unlock 4DX Revenue

PE Ratio Range

4DX PE Ratio Range Unlock 4DX Revenue

Dividend Yield Range

4DX Dividend Yield Range Unlock 4DX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4DX EPS Forecasts Unlock 4DX Revenue
Profile Summary

4DMedical Limited is an Australia-based medical technology company. The Company offers XV Technology. The XV Technology is a four-dimensional lung imaging technology that utilizes mathematic models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing X-ray machines. Using specific settings and protocols, the data from a patient’s X-ray images are sent to the 4DMedical cloud where it is analyzed by 4DMedical and returned to the physician as a comprehensive report of quantitative four-dimensional lung function data. The ventilation analysis performed by XV Ventilation Analysis provides physicians with a patient’s regional measurements of ventilation at each phase of the breath, delivering functional data on lung health.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 264,762,405
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4DX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4DX
Upcoming Events for 4DX
Thursday 26th August, 2021 Estimate
Full Year 2021 4DMedical Ltd Earnings Release
Thursday 18th November, 2021 Estimate
4DMedical Ltd Annual Shareholders Meeting
Frequently Asked Questions for 4DMedical
What is the 4DMedical share price?

As of 18/06/21, shares in 4DMedical are trading at A$1.38, giving the company a market capitalisation of £197.5m. This share price information is delayed by 15 minutes.

How has the 4DMedical share price performed this year?

Shares in 4DMedical are currently trading at A$1.38 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the 4DMedical price has moved by % over the past year.

What are the analyst and broker recommendations for 4DMedical?

There are no analysts currently covering 4DMedical.

When will 4DMedical next release its financial results?

4DMedical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the 4DMedical dividend yield?

4DMedical does not currently pay a dividend.

Does 4DMedical pay a dividend?

4DMedical does not currently pay a dividend.

When does 4DMedical next pay dividends?

4DMedical does not currently pay a dividend.

How do I buy 4DMedical shares?

To buy shares in 4DMedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of 4DMedical?

Shares in 4DMedical are currently trading at A$1.38, giving the company a market capitalisation of £197.5m.

Where are 4DMedical shares listed? Where are 4DMedical shares listed?

Here are the trading details for 4DMedical:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: 4DX
What kind of share is 4DMedical?

Based on an overall assessment of its quality, value and momentum, 4DMedical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a 4DMedical share price forecast 2021?

Shares in 4DMedical are currently priced at A$1.38. At that level they are trading at 38.18% discount to the analyst consensus target price of 0.00.

Analysts covering 4DMedical currently have a consensus Earnings Per Share (EPS) forecast of -0.056 for the next financial year.

How can I tell whether the 4DMedical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4DMedical. Over the past six months, the relative strength of its shares against the market has been -45.5%. At the current price of A$1.38, shares in 4DMedical are trading at -26% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the 4DMedical PE Ratio?

We were not able to find PE ratio data for 4DMedical.

Who are the key directors of 4DMedical?

We were unable to find the directors for 4DMedical.

Who are the major shareholders of 4DMedical?

Here are the top five shareholders of 4DMedical based on the size of their shareholding:

Fouras (Andreas) Individual Investor
Percentage owned: 31.3% (64.8m shares)
Perennial Value Management Ltd. Investment Advisor
Percentage owned: 7.79% (16.1m shares)
Oh-Rule Pty. Ltd. Corporation
Percentage owned: 1.89% (3.91m shares)
FIL Investment Management (Australia) Limited Investment Advisor
Percentage owned: 1.77% (3.66m shares)
Fidelity Future Leaders Fund Mutual Fund
Percentage owned: 1.77% (3.66m shares)
Similar to 4DX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.